BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meduri GU, Annane D, Confalonieri M, Chrousos GP, Rochwerg B, Busby A, Ruaro B, Meibohm B. Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS. Intensive Care Med 2020;46:2284-96. [PMID: 33150472 DOI: 10.1007/s00134-020-06289-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Torres A, Motos A, Cillóniz C, Ceccato A, Fernández-Barat L, Gabarrús A, Bermejo-Martin J, Ferrer R, Riera J, Pérez-Arnal R, García-Gasulla D, Peñuelas O, Lorente JÁ, de Gonzalo-Calvo D, Almansa R, Menéndez R, Palomeque A, Villar RA, Añón JM, Balan Mariño A, Barberà C, Barberán J, Blandino Ortiz A, Boado MV, Bustamante-Munguira E, Caballero J, Cantón-Bulnes ML, Carbajales Pérez C, Carbonell N, Catalán-González M, de Frutos R, Franco N, Galbán C, Gumucio-Sanguino VD, de la Torre MDC, Díaz E, Estella Á, Gallego E, García Garmendia JL, Gómez JM, Huerta A, García RNJ, Loza-Vázquez A, Marin-Corral J, Martin Delgado MC, Martínez de la Gándara A, Martínez Varela I, López Messa J, Albaiceta GM, Nieto M, Novo MA, Peñasco Y, Pérez-García F, Pozo-Laderas JC, Ricart P, Sagredo V, Sánchez-Miralles A, Sancho Chinesta S, Serra-Fortuny M, Socias L, Solé-Violan J, Suarez-Sipmann F, Tamayo Lomas L, Trenado J, Úbeda A, Valdivia LJ, Vidal P, Barbé F; CIBERESUCICOVID Project Investigators. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study. Intensive Care Med 2022. [PMID: 35727348 DOI: 10.1007/s00134-022-06726-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ruaro B, Confalonieri P, Pozzan R, Tavano S, Mondini L, Baratella E, Pagnin A, Lerda S, Geri P, Biolo M, Confalonieri M, Salton F. Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? JCM 2022;11:3577. [DOI: 10.3390/jcm11133577] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Dey R, Bishayi B. Ascorbic acid along with ciprofloxacin regulates S. aureus induced microglial inflammatory responses and oxidative stress through TLR-2 and glucocorticoid receptor modulation. Inflammopharmacology 2022. [PMID: 35704229 DOI: 10.1007/s10787-022-01012-z] [Reference Citation Analysis]
4 Salton F, Confalonieri P, Campisciano G, Cifaldi R, Rizzardi C, Generali D, Pozzan R, Tavano S, Bozzi C, Lapadula G, Meduri GU, Confalonieri M, Comar M, Lerda S, Ruaro B. Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS. J Clin Med 2022;11:2951. [PMID: 35683340 DOI: 10.3390/jcm11112951] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Meduri GU, Shih MC, Bridges L, Martin TJ, El-Solh A, Seam N, Davis-Karim A, Umberger R, Anzueto A, Sriram P, Lan C, Restrepo MI, Guardiola JJ, Buck T, Johnson DP, Suffredini A, Bell WA, Lin J, Zhao L, Uyeda L, Nielsen L, Huang GD; ESCAPe Study Group. Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med 2022. [PMID: 35723686 DOI: 10.1007/s00134-022-06684-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen CC, Yang YP, Tsai HL, Tung TH. Effects of Tocilizumab on Adults With COVID-19 Pneumonia: A Meta-Analysis. Front Med (Lausanne) 2022;9:838904. [PMID: 35433719 DOI: 10.3389/fmed.2022.838904] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 McGovern AJ, González J, Ramírez D, Barreto GE. Identification of HMGCR, PPGARG and prohibitin as potential druggable targets of dihydrotestosterone for treatment against traumatic brain injury using system pharmacology. Int Immunopharmacol 2022;108:108721. [PMID: 35344815 DOI: 10.1016/j.intimp.2022.108721] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pelosi P, Tonelli R, Torregiani C, Baratella E, Confalonieri M, Battaglini D, Marchioni A, Confalonieri P, Clini E, Salton F, Ruaro B. Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update. JCM 2022;11:1704. [DOI: 10.3390/jcm11061704] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
9 Maláska J, Stašek J, Duška F, Balík M, Máca J, Hruda J, Vymazal T, Klementová O, Zatloukal J, Gabrhelík T, Novotný P, Demlová R, Kubátová J, Vinklerová J, Svobodník A, Kratochvíl M, Klučka J, Gál R, Singer M; REMED Study Group. Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)-study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial. Trials 2022;23:35. [PMID: 35033182 DOI: 10.1186/s13063-021-05963-6] [Reference Citation Analysis]
10 Joshi S, Smith Z, Soman S, Jain S, Yako A, Hojeij M, Massoud L, Alsaadi A, Williams J, Kenney R, Miller J, Alangaden G, Ramesh M. Low- Versus High-Dose Methylprednisolone in Adult Patients With Coronavirus Disease 2019: Less Is More. Open Forum Infect Dis 2022;9:ofab619. [PMID: 35024376 DOI: 10.1093/ofid/ofab619] [Reference Citation Analysis]
11 Kubra KT, Uddin MA, Akhter MS, Leo AJ, Siejka A, Barabutis N. P53 mediates the protective effects of metformin in inflamed lung endothelial cells. Int Immunopharmacol 2021;:108367. [PMID: 34794886 DOI: 10.1016/j.intimp.2021.108367] [Reference Citation Analysis]
12 Landolf KM, Lemieux SM, Rose C, Johnston JP, Adams CD, Altshuler J, Berger K, Dixit D, Effendi MK, Heavner MS, Lemieux D, Littlefield AJ, Nei AM, Owusu KA, Rinehart M, Robbins B, Rouse GE, Thompson Bastin ML. Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID-19): A systematic review. Pharmacotherapy 2021. [PMID: 34662448 DOI: 10.1002/phar.2637] [Reference Citation Analysis]
13 Luo MH, Qian YQ, Huang DL, Luo JC, Su Y, Wang H, Yu SJ, Liu K, Tu GW, Luo Z. Tailoring glucocorticoids in patients with severe COVID-19: a narrative review. Ann Transl Med 2021;9:1261. [PMID: 34532398 DOI: 10.21037/atm-21-1783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Birudaraju D, Hamal S, Tayek JA. Solumedrol Treatment for Severe Sepsis in Humans with a Blunted Adrenocorticotropic Hormone-Cortisol Response: A Prospective Randomized Double-Blind Placebo-Controlled Pilot Clinical Trial. J Intensive Care Med 2021;:8850666211038883. [PMID: 34516312 DOI: 10.1177/08850666211038883] [Reference Citation Analysis]
15 Baratella E, Ruaro B, Marrocchio C, Starvaggi N, Salton F, Giudici F, Quaia E, Confalonieri M, Cova MA. Interstitial Lung Disease at High Resolution CT after SARS-CoV-2-Related Acute Respiratory Distress Syndrome According to Pulmonary Segmental Anatomy. J Clin Med 2021;10:3985. [PMID: 34501430 DOI: 10.3390/jcm10173985] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Mouri A, Kaira K, Yamaguchi O, Hashimoto K, Miura Y, Shiono A, Shinomiya S, Imai H, Kobayashi K, Kagamu H. Effect of Systemic Steroid Use for Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Receiving PD-1 Blockade Drugs. J Clin Med 2021;10:3744. [PMID: 34442054 DOI: 10.3390/jcm10163744] [Reference Citation Analysis]
17 Confalonieri M, Salton F, Confalonieri P, Rochwerg B, Meduri GU. Caution When Comparing the Impact of Corticosteroids in COVID-19. Chest 2021;160:e243-4. [PMID: 34366052 DOI: 10.1016/j.chest.2021.04.026] [Reference Citation Analysis]
18 De Luca D, Autilio C. Strategies to protect surfactant and enhance its activity. Biomed J 2021:S2319-4170(21)00099-8. [PMID: 34365021 DOI: 10.1016/j.bj.2021.07.011] [Reference Citation Analysis]
19 Dupuis C, de Montmollin E, Buetti N, Goldgran-Toledano D, Reignier J, Schwebel C, Domitile J, Neuville M, Ursino M, Siami S, Ruckly S, Alberti C, Mourvillier B, Bailly S, Laurent V, Gainnier M, Souweine B, Timsit JF; OutcomeReaTM research network. Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network. PLoS One 2021;16:e0255644. [PMID: 34347836 DOI: 10.1371/journal.pone.0255644] [Reference Citation Analysis]
20 Ozdemir R, Gokce IK, Taslidere AC, Tanbek K, Gul CC, Sandal S, Turgut H, Kaya H, Aslan M. Does Chrysin prevent severe lung damage in Hyperoxia-Induced lung injury Model? Int Immunopharmacol 2021;99:108033. [PMID: 34343938 DOI: 10.1016/j.intimp.2021.108033] [Reference Citation Analysis]
21 Zhang L, Wang Z, Xu F, Ren Y, Wang H, Han D, Lyu J, Yin H. The Role of Glucocorticoids in the Treatment of ARDS: A Multicenter Retrospective Study Based on the eICU Collaborative Research Database. Front Med (Lausanne) 2021;8:678260. [PMID: 34381796 DOI: 10.3389/fmed.2021.678260] [Reference Citation Analysis]
22 Yuan S, Jiang SC, Zhang ZW, Fu YF, Hu J, Li ZL. The Role of Alveolar Edema in COVID-19. Cells 2021;10:1897. [PMID: 34440665 DOI: 10.3390/cells10081897] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Zha YF, Xie J, Ding P, Zhu CL, Li P, Zhao ZZ, Li YH, Wang JF. Senkyunolide I protect against lung injury via inhibiting formation of neutrophil extracellular trap in a murine model of cecal ligation and puncture. Int Immunopharmacol 2021;99:107922. [PMID: 34224996 DOI: 10.1016/j.intimp.2021.107922] [Reference Citation Analysis]
24 Çakmak F, Demirbuga A, Demirkol D, Gümüş S, Torun SH, Kayaalp GK, Ömeroglu RE, Somer A, Uysalol M, Yıldız R, Ayaz NA. Nailfold capillaroscopy: A sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection. Microvasc Res 2021;138:104196. [PMID: 34097919 DOI: 10.1016/j.mvr.2021.104196] [Reference Citation Analysis]
25 Ruaro B, Confalonieri P, Santagiuliana M, Wade B, Baratella E, Kodric M, Berria M, Jaber M, Torregiani C, Bruni C, Confalonieri M, Salton F. Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated. J Clin Med 2021;10:2462. [PMID: 34199396 DOI: 10.3390/jcm10112462] [Reference Citation Analysis]
26 Kuindersma M, Diaz RR, Spronk PE. Tailored modulation of the inflammatory balance in COVID-19 patients admitted to the ICU?-a viewpoint. Crit Care 2021;25:178. [PMID: 34034789 DOI: 10.1186/s13054-021-03607-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wu S, Ye H, Xue T, Wang J. Mechanism of lipopolysaccharide-mediated induction of epithelial-mesenchymal transition of alveolar type II epithelial cells in absence of other inflammatory cells. Eur J Inflamm 2021;19:205873922110144. [DOI: 10.1177/20587392211014427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ruaro B, Salton F, Braga L, Wade B, Confalonieri P, Volpe MC, Baratella E, Maiocchi S, Confalonieri M. The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung. Int J Mol Sci 2021;22:2566. [PMID: 33806395 DOI: 10.3390/ijms22052566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
29 Nasonov EL. Coronavirus disease 2019 (COVID-19) and autoimmunity. Naučno-praktičeskaâ revmatologiâ 2021;59:5-30. [DOI: 10.47360/1995-4484-2021-5-30] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 14.0] [Reference Citation Analysis]
30 Meduri GU, Chrousos GP, Arabi YM. The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply. Intensive Care Med 2021;47:357-8. [PMID: 33507321 DOI: 10.1007/s00134-020-06335-5] [Reference Citation Analysis]